Sotera Health (SHC) EBITDA (2020 - 2026)

Sotera Health's EBITDA history runs 7 years deep, the most recent figure standing at $10.5 million for Q1 2026.

• In Q1 2026, EBITDA rose 89.36% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $181.3 million (up 504.87% YoY), while the FY2025 annual figure was $176.4 million, up 347.8% from the prior year.
• EBITDA was $10.5 million for Q1 2026 at Sotera Health, down from $50.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $89.1 million in Q2 2025 to a low of -$262.4 million in Q4 2022.
• Historically, EBITDA has averaged -$4.4 million across 5 years, with a median of $5.5 million in 2025.
• The sharpest annual moves came in 2022 and 2025: EBITDA plunged 3159.33% in 2022, then surged 630.93% in 2025.
• A 5-year view of EBITDA shows it stood at -$262.4 million in 2022, then soared by 122.92% to $60.1 million in 2023, then slumped by 218.57% to -$71.3 million in 2024, then soared by 170.84% to $50.5 million in 2025, then sank by 79.24% to $10.5 million in 2026.
• The last three EBITDA figures came in at $10.5 million (Q1 2026), $50.5 million (Q4 2025), and $31.2 million (Q3 2025), per Business Quant data.